Age-related changes of serum soluble interleukin 9 receptor (sIL-9Rα) in healthy subjects

Indian Journal of Clinical Biochemistry

Volumn 27, Issue 4, 2012, Pages 400-404

  Okamoto, Yoshihiro ^a   Tanaka, Mayuri ^a   Kasahara, Asami ^a   Hara, Takazumi ^a   Gotoh, Yoshimitsu ^b   Fujita, Naoya ^c   Fukui, Takashi ^a   Masuzawa, Toshiyuki ^a  

^a CHIBA INSTITUTE OF SCIENCE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

Author keywords

ELISA; Hemolytic uremic syndrome (HUS); Soluble interleukin 9 receptor chain (sIL 9R )

Indexed keywords

CREATININE; INTERLEUKIN 9 RECEPTOR; SODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHILD; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFANT; JAPANESE; MALE; NORMAL HUMAN; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SODIUM BLOOD LEVEL;

EID: 84867897812     PISSN: 09701915     EISSN: 09740422     Source Type: Journal    
DOI: 10.1007/s12291-012-0216-9     Document Type: Article

References (25)

1. Soussi-Gounni A, Kontolemos M, Hamid Q. Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol. 2001;107:575-82.
2. Ciprandi G, De Amici M, Castellazzi AM, Tosca MA, Marseglia G. Serum IL-9 levels depend on allergen exposure: preliminary study. Int Arch Allergy Immunol. 2011;154:246-8.
3. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S. Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol. 2011;38:2193-7.
4. Soroosh P, Doherty TA. Th9 and allergic disease. Immunology. 2009;127:450-8.
5. Demoulin JB, Renauld JC. Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol. 1998;16:345-64.
6. Renauld JC, Kermouni A, Vink A, Louahed J, Van Snick J. Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol. 1995;57:353-60.
7. Heaney ML, Golde DW. Soluble cytokine receptors. Blood. 1996;87:847-57.
8. Levine SJ. Mechanisms of soluble cytokine receptor generation. J Immunol. 2004;173:5343-8.
9. Levine SJ. Molecular mechanisms of soluble cytokine receptor generation. J Biol Chem. 2008;283:14177-81.
10. Okamoto Y, Tanaka M, Nagai T, Gotoh Y, Fujita N, Fukui T, Masuzawa T. Urinary evaluation of the balance between the soluble interferon-gamma receptor (IFN-gammaR1) and the interleukin-4 receptor (IL-4Ralpha) in children with vesicoureteral reflux. J Immunoass Immunochem. 2009;30:378-85.
11. Okamoto Y, Seta K, Nakajo I, Gotoh Y, Nagai T, Fujita N, Fukui T, Masuzawa T. Age-dependent decrease in serum soluble interferon-gamma receptor (sIFN-gammaR) in healthy Japanese individuals; population study of serum sIFN-gammaR level in Japanese. J Immunoass Immunochem. 2008;29:234-43.
12. Fujita N, Okamoto Y, Gotoh Y, Yada Y, Suzuki Y, Ando T, Togari H, Nishida M. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors. Cytokine. 2005;32:143-8.
13. Sack U, Burkhardt U, Borte M, Schadlich H, Berg K, Emmrich F. Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol. 1998;5:28-32.
14. Gotoh Y, Okamoto Y, Uemura O, Mori N, Tanaka S, Ando T, Nishida M. Determination of age-related changes in human soluble interleukin 2 receptor in body fluids of normal subjects as a control value against disease states. Clin Chim Acta. 1999;289:89-97.
15. Okada M, Takemura T. Guidelines for the diagnosis and treatment of hemolytic uremic syndrome (HUS) with enterohemorrhagic colitis (Japanese Society of Pediatric Nephrology). Nippon Rinsho. 2003;61(Suppl 2):657-60.
16. Bale JF Jr, Brasher C, Siegler RL. CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child. 1980;134:869-72.
17. Okamoto Y, Tanaka M, Miyahara N, Tanabe M, Gotoh Y, Fujita N, Fukui T, Masuzawa T. Determination of the age-related changes of serum basic fibroblast growth factor (bFGF) level in healthy Japanese subjects. Clin Lab. 2009;55:114-9.
18. Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Pediatr Res. 2002;52:928-34.
19. Proulx F, Turgeon JP, Litalien C, Mariscalco MM, Robitaille P, Seidman E. Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome. Pediatr Infect Dis J. 1998;17:899-904.
20. Yamamoto T, Nagayama K, Satomura K, Honda T, Okada S. Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157. Nephron. 2000;84:326-32.
21. Westerholt S, Hartung T, Tollens M, Gustrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R. Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues. Cytokine. 2000;12:822-7.
22. Lopez EL, Contrini MM, Devoto S, de Rosa MF, Grana MG, Genero MH, Canepa C, Gomez HF, Cleary TG. Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina. Pediatr Infect Dis J. 1995;14:594-8.
23. Karpman D, Andreasson A, Thysell H, Kaplan BS, Svanborg C. Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol. 1995;9:694-9.
24. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985;151:775-82.
25. Rowe PC, Orrbine E, Wells GA, McLaine PN. Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre. J Pediatr. 1991;1991(119):218-24.